NEW AIDH DIGITAL STRATEGY ADDS PILLAR TO PREVIOUS AIMS Nurturing, supporting and advancing AIDH members’ professional lives
With
Anja Nikolic,
Chief Executive Officer
Australasian Institute of Digital Health
SEGMENT
Filmed in Melbourne & Sydney | March 2026
Australasian Institute of Digital Health (AIDH), today has released the AIDH Strategic Plan for 2026–2028, recently approved by the Board. This plan acts as a roadmap, as well as a shared statement of purpose and intent, guiding where AIDH will focus its effort, investment and voice over the next three years.
Australian Health Journal spoke with Anja Nikolic, AIDH Chief Executive Officer on AIDH’s role as a hub for collaboration, knowledge advancement and thought leadership across the sector.
Drawing upon the previous strategic plan ending 2025, the new plan as a new pillar.
The plan commits AIDH to continuing its work in building a highly skilled and capable workforce, shaping healthcare through strong thought leadership, and fostering a diverse and engaged community. Importantly, it introduces an additional strategic aim — nurturing a thriving and growing membership — because its impact relies on a strong, supported and connected member base.
Underlying themes are AIDH’s commitment to organisational excellence, guided by its values of professionalism, excellence, integrity, respect and teamwork.
The Strategic Plan was developed collaboratively, drawing on the insight and experience of staff, the Board, members and stakeholders.
AIDH members and stakeholders are invited to read the plan and consider how they can support its delivery — through their involvement, their ideas, and their advocacy for AIDH and the digital health community.
Source: Supplied and adapted
-
Imperatives for women diagnosed with ovarian cancer
Professor Clare Scott, a pioneering clinician scientist at the Walter and Eliza Hall Institute of Medical Research in Melbourne, also serves as a medical oncologist at Peter MacCallum Cancer Centre, the Royal Melbourne Hospital, and the Royal Women’s Hospital.
Her comprehensive training in medical oncology has fuelled her specialisation in gynaecological cancer, combining rigorous research with clinical trials to improve patient outcomes. With over a decade of involvement in ANZGOG, Australia’s foremost gynaecologic cancer research organisation, she is deeply committed to advancing research and saving lives.
-
The quest to create an Australian framework for a Palliative Care Pharmacist
Helen Stone is the State and Territory Manager SA & NT for the Pharmaceutical Society Australia. Her professional interests include palliative care, pharmacist professional services, mental health, leadership, and management.
She has recently led teams of pharmacists in innovative pharmacy practice models including in aged care, GP practice, palliative care and dementia support. This has contributed to the body of evidence for sustainable funding for embedded pharmacist roles in primary care and aged care settings.
-
Mission to raise awareness of sarcoma and need for clinical trial funding
Sarcoma, a rare and aggressive cancer, remains the deadliest cancer for children and young adults, accounting for nearly one third (30%) of cancer-related deaths among those aged 15–24 and one tenth (10%) of those aged 0–14. Further, still severely under-diagnosed, sarcoma only accounts for one sixth (15%) of all cancer diagnoses in the 15 – 24 age group, and less than a tenth (8%) among children under 10.
